Back to Search
Start Over
Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic
- Source :
- HemaSphere, Vol 4, Iss 4, p e433 (2020), HemaSphere
- Publication Year :
- 2020
- Publisher :
- Wolters Kluwer, 2020.
-
Abstract
- In the light of the COVID-19 pandemic, the International Workshop on Waldenström Macroglobulinemia (IWWM) Treatment Recommendations Panel felt the need to provide a consensus statement for the management of Waldenström Macroglobulinemia (WM) patients during this challenging time. We followed the current recommendations by the American Society of Hematology, which have been modified accordingly to fit the specific realities associated with the management of WM. In this Consensus Statement, the Panel addresses questions related to treatment initiation, preferred therapies, minimizing visit to clinics and infusions centers, supportive care and guidance for WM patients in clinical trials. Finally, we also provide information on timing and appropriateness of testing and management of COVID-19 infected patients, as well as ways to get physicians and patients involved in registry studies that could help others.
- Subjects :
- medicine.medical_specialty
2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19)
business.industry
Statement (logic)
lcsh:RC633-647.5
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
MEDLINE
Waldenstrom macroglobulinemia
Hematology
lcsh:Diseases of the blood and blood-forming organs
medicine.disease
Clinical trial
Guideline Article - Expert opinion
Pandemic
Medicine
business
Intensive care medicine
Subjects
Details
- Language :
- English
- ISSN :
- 25729241
- Volume :
- 4
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- HemaSphere
- Accession number :
- edsair.doi.dedup.....e484774f72b9d0c8b879f587fd99c570